blog-icon

Clinical research blog

Explore our blog for insights into the big questions in precision medicine and clinical research.

The All of Us milestone shows precision medicine’s next infrastructure challenge

The NIH’s All of Us Research Program has become the world’s largest integrated genomic and electronic health record database. Its June 30 data release includes ...
Continue reading

Reducing screen failure starts with better trial design

When a clinical trial misses its enrollment targets, the instinct is often to look at recruitment through more channels, more outreach, and a bigger advertising...
Continue reading

Rethinking drug approval for ultra-rare disease: Inside the UK’s n-of-1 ASO trial

Last week, the rare disease field celebrated another breakthrough. A teenage girl with an ultra-rare genetic neurodegenerative disease was treated with a bespok...
Continue reading

Lessons from recent FDA actions in precision medicine 

Over the past few years, several cell and gene therapies (CGTs) in precision medicine have received FDA Complete Response Letters (CRLs). As the agency increase...
Continue reading

Top five regulatory signals sponsors can act on now

The FDA’s activity in 2025 reflected a mix of scientific progress and operational instability. Precision medicine programs benefitted from new draft guidance, r...
Continue reading

Expediting study start-up: Best practices for sponsors

Study start-up is a critical stage of the drug development process and can have a major impact on trial timelines, budgets, and overall success. Start-up activi...
Continue reading

Clinical trial budgeting: Smarter strategies for biotech

Clinical trials have always been burdensome on sponsors, but in the current biotech landscape, the pressure to execute trials promptly, efficiently, and in a co...
Continue reading

The future of AI in clinical research: A conversation with Sano’s CTO

At Sano Genetics, our mission is to deliver and facilitate clinical trials that accelerate the development of precision medicine treatments for patients. As a c...
Continue reading

Master protocols in precision medicine: Basket, umbrella, and platform trials explained

Precision medicine has fundamentally changed how diseases are defined and how therapies are developed — shifting eligibility from clinical phenotype to molecula...
Continue reading

Supporting sites in modern trials: Tackling tech fatigue and enabling smarter decentralization

Fostering and maintaining a high standard for site engagement are key priorities for sponsors as they can enhance the likelihood of effective and timely trial e...
Continue reading